Does the repeat dose of gonadotropin-releasing hormone agonist trigger in polycystic ovarian syndrome improve in vitro fertilization cycles outcome? A clinical trial study

Does the repeat dose of gonadotropin-releasing hormone agonist trigger in polycystic ovarian syndrome improve in vitro fertilization cycles outcome? A clinical trial study

Background: A repeat dose of Gonadotropin-releasing Hormone (GnRH) agonist could provide long duration of luteinizing hormone (LH) surge and amplitude appropriately. Objective: Improvement in oocyte maturity could be obtained by a repeat dose of GnRH agonist. Materials and Methods: In this randomize...

Full description

Bibliographic Details
Main Authors:	Abbas Aflatoonian, Fatemeh Haghighi, Masrooreh Hoseini, Saeid Haghdani
Format:	Article
Language:	English
Published:	Shahid Sadoughi University of Medical Sciences 2020-07-01
Series:	International Journal of Reproductive BioMedicine
Subjects:	polycystic ovarian syndrome, treatment, in vitro fertilization, gonadotropin-releasing hormone.
Online Access:	https://doi.org/10.18502/ijrm.v13i7.7363

Similar Items

Can We Harvest More Mature Oocytes by Repeating Gonadotropin-Releasing Hormone Agonist Doses in Polycystic Ovarian Syndrome Patients at Risk of OHSS in Antagonist Cycles? A Randomised Clinical Trial
by: Seyedeh houra Hashemi, et al.
Published: (2024-06-01)

Comparison of gonadotropin-releasing hormone agonist with GnRH antagonist in polycystic ovary syndrome patients undergoing in vitro fertilization cycle: Retrospective analysis from a tertiary center and review of literature
by: Neeta Singh, et al.
Published: (2014-01-01)

Correction to “Does the repeat dose of gonadotropin-releasing hormone agonist trigger in polycystic ovarian syndrome improve in vitro fertilization cycles outcome? A clinical trial study” [Int J Reprod BioMed 2020; 18: 485-490]
by: Abbas Aflatoonian, et al.
Published: (2022-07-01)

Effect of gonadotropin-releasing hormone agonist on ES-2 ovarian cancer cells
by: Kuan-Hao Tsui, et al.
Published: (2014-03-01)

Investigation of pregnancy outcome and ovarian hyper stimulation syndrome prevention in agonist and antagonist gonadotropin-releasing hormone protocol
by: Behnaz Khani Rabati, et al.
Published: (2012-01-01)

Role of Gonadotropin-Releasing Hormone (GnRH) in Ovarian Cancer
by: Carsten Gründker, et al.
Published: (2021-02-01)

Ovarian Cyst Formation Following Gonadotropin-Releasing Hormone-Agonist Administration Decreases the Oocyte Quality in IVF Cycles
by: Muammer Doğan, et al.
Published: (2012-06-01)

Effects of Crocin on Ovarian Follicle and Serum Sex Hormone in Letrozole-Induced Polycystic Ovarian Syndrome in Rat Model
by: Seyeddamoon Sadoughi
Published: (2017-07-01)

Fixed versus flexible gonadotropin releasing hormone antagonist protocol in women with polycystic ovary syndrome undergoing in vitro fertilization: An RCT
by: Hanieh Fatehi, et al.
Published: (2024-10-01)

Pregnancy outcome in long- versus short-acting gonadotropin-releasing hormone agonist cycles in participants with normal ovarian reserve: An RCT
by: Roya Kabodmehri, et al.
Published: (2023-10-01)

Clinical efficacy of dual trigger with human chorionic gonadotropin and a gonadotropin‐releasing hormone agonist for women undergoing fertility preservation
by: Yeon Hee Hong, et al.
Published: (2022-01-01)

Gonadotropin releasing hormone analogue treatment of central precocious puberty is not associated with altered prevalence of polycystic ovary syndrome: a single center cohort study
by: Gilad Karavani, et al.
Published: (2021-09-01)

Severe Ovarian Hyperstimulation Syndrome despite low dose stimulation in Polycystic Ovarian Syndrome
by: Robin George Manappallil, et al.
Published: (2019-05-01)

Low dose human chorionic gonadotropin administration at the time of gonadotropin releasing-hormone agonist trigger versus 35 h later in women at high risk of developing ovarian hyperstimulation syndrome – a prospective randomized double-blind clinical trial
by: L. L. Engmann, et al.
Published: (2019-01-01)

Fertility Preservation and Ovarian Hyperstimulation Syndrome Management in Cancer Care: A Pathophysiological Perspective on Gonadotropin-Releasing Hormone Agonists and Antagonists
by: Giuliano Bedoschi, et al.
Published: (2024-06-01)

Prediction of Successful Ovarian Protection Using Gonadotropin-Releasing Hormone Agonists During Chemotherapy in Young Estrogen Receptor-Negative Breast Cancer Patients
by: Dong-Yun Lee, et al.
Published: (2020-06-01)

Progesterone-primed ovarian stimulation in polycystic ovarian syndrome: An RCT
by: Maryam Eftekhar, et al.
Published: (2019-09-01)

A Case of Thromboembolism After Injection of Gonadotropin-releasing Hormone Agonist
by: Feng Zhou, et al.
Published: (2016-01-01)

Gonadotropin-releasing hormone agonist protects ovarian function in young patients with ovarian malignancy undergoing platinum-based chemotherapy: A prospective study
by: Ya Xie, et al.
Published: (2022-10-01)

Gonadotropin-releasing hormone agonists during chemotherapy for ovarian function and fertility preservation for patients with early-stage breast cancer
by: Abdel-Razeq H
Published: (2019-05-01)

Functional Ovarian Cysts in Artificial Frozen-Thawed Embryo Transfer Cycles With Depot Gonadotropin-Releasing Hormone Agonist
by: Hui Ji, et al.
Published: (2022-04-01)

Transcriptome profiling reveals superovulation with the gonadotropin-releasing hormone agonist trigger impaired embryo implantation in mice
by: Meng Li, et al.
Published: (2024-02-01)

Soft ovarian stimulation protocol in polycystic ovary syndromes women inspired by gonadotropin stimulated intrauterine insemination cycles converted to rescue IVF: time to shift the focus “retrospective study”
by: Amina Nagy Elasy, et al.
Published: (2023-02-01)

Aggressive angiomyxoma of the vulva: dramatic response to gonadotropin-releasing hormone agonist therapy
by: Azar Danesh, et al.
Published: (2007-08-01)

Thyroid Dysfunction Associated with Administration of the Long-Acting Gonadotropin-Releasing Hormone Agonist
by: Eun Jin Han, et al.
Published: (2013-09-01)

The use of gonadotropin-releasing hormone antagonist in women undergoing intrauterine insemination
by: M Yousef Elsemary, et al.
Published: (2019-01-01)

Basal and dynamic relationships between serum anti-Müllerian hormone and gonadotropins in patients with functional hypothalamic amenorrhea, with or without polycystic ovarian morphology
by: Marlene Hager, et al.
Published: (2022-07-01)

Effect of vaginal estriol use in total laparoscopic hysterectomy with gonadotropin-releasing hormone agonist therapy
by: Go Hirata, et al.
Published: (2018-01-01)

Gonadotropin releasing hormone agonists: Expanding vistas
by: Navneet Magon
Published: (2011-01-01)

Effect of luteal phase support gonadotropin-releasing hormone agonist on the endometrial receptivity and outcomes of in vitro fertilization programs
by: E M Savelyeva, et al.
Published: (2016-06-01)

Effects of gonadotropin-releasing hormone agonist treatment on final adult height in boys with idiopathic central precocious puberty
by: Ah Young Cho, et al.
Published: (2021-12-01)

Mild ovarian stimulation with letrozole plus fixed dose human menopausal gonadotropin prior to IVF/ICSI for infertile non-obese women with polycystic ovarian syndrome being pre-treated with metformin: a pilot study
by: Giuseppe D’Amato, et al.
Published: (2018-09-01)

Progress and Challenges in the Search for the Mechanisms of Pulsatile Gonadotropin-Releasing Hormone Secretion
by: Stephanie Constantin
Published: (2017-07-01)

The effect of dienogest and gonadotropin-releasing hormone agonist on pelvic pain after laparoscopic surgery for endometriosis: An RCT
by: Fatemeh Davari Tanha, et al.
Published: (2025-02-01)

Endometrial preparation using gonadotropin-releasing hormone agonist prior to frozen-thawed embryo transfer in women with repeated implantation failure: An RCT
by: Robab Davar, et al.
Published: (2020-05-01)

Use of a Gonadotropin-Releasing Hormone Agonist to Manage Perimenopausal Women With Symptomatic Uterine Myomas
by: Peng-Hui Wang, et al.
Published: (2009-06-01)

Association of follicular fluid volume with membrane stretchability of human metaphase II oocytes following the gonadotropin‐releasing hormone agonist protocol during intracytoplasmic sperm injection
by: Taketo Inoue, et al.
Published: (2018-07-01)

Evaluation of Ovarian Histomorphology and Function Following Clomiphene Citrate and Human Chorionic Gonadotropin Administration in Wistar Rats
by: O. U. Idemudia, et al.
Published: (2024-03-01)

Risk factors for empty follicle syndrome in assisted reproductive technology with gonadotropin‐releasing hormone agonist trigger
by: Daichi Inoue, et al.
Published: (2023-01-01)

Use of Buserelin depot, a gonadotropin-releasing hormone agonist, in the treatment of prostate cancer
by: L. M. Rapoport, et al.
Published: (2014-12-01)